From Seekingalpha · · 30s
Aemetis Faces Financing Risks Despite Q3 Gains
Aemetis' Q3 results show improved operations but persistent financing risks keep it a sell.
In brief
Aemetis' Q3 results show improved operations but persistent financing risks keep it a sell. Aemetis' Q3 adjusted EBITDA rose to $24.8M but heavy liabilities and uncertain India segment performance outweigh RNG growth prospects. Originally reported by Seekingalpha.
Q3 Results
Aemetis' Q3 adjusted EBITDA rose to $24.8M but $11M was a one-off credit recalculation.
Cash Flow Shortfall
Cash flow from operations insufficient to cover $35.3M in investments.
Financing Challenges
Heavy liabilities, expensive financing, and uncertain India segment performance outweigh RNG growth prospects.
At a glance
Aemetis' Q3 adjusted EBITDA rose to $24.8M but heavy liabilities and uncertain India segment performance outweigh RNG growth prospects.
